Sesderma Recalls Repaskin 50 Sunscreen Due to cGMP Deviations
Sesderma is recalling 15 tubes of Repaskin 50 sunscreen because the product does not comply with current Good Manufacturing Practice (cGMP) requirements.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a situation where use of the product might cause temporary or medically reversible health consequences, or where the probability of serious adverse health consequences is remote. The source text cites cGMP deviations without reporting specific injuries or illnesses, aligning with a Moderate severity rating for a voluntary compliance recall.
Plain-English summary
Sesderma, SL is recalling 15 tubes of Repaskin 50 (octocrylene 7%, titanium dioxide 2%) Body Lotion Sunscreen gel cream, Broad Spectrum SPF 50, 6.8 fl oz (200 mL). The product is identified by Lot code 41464901 and an expiration date of 05/17.
The recall was initiated because the product does not comply with current Good Manufacturing Practice (cGMP) requirements. The agency has classified this recall as Class II.
The affected product was distributed to Florida, Puerto Rico, Colorado, and Georgia. Consumers should check their inventory for the specific lot code and expiration date listed above. If the product matches the description, consumers should stop using it and contact the manufacturer for instructions.
The recalled product
- Product
- Repaskin 50 (octocrylene 7%, titanium dioxide 2%) Body Lotion Sunscreen gel cream, Broad Spectrum SPF 50, 6.8 fl oz (200 mL) tube, over the counter, Manufactured by Sesderma S.L., Valencia, Spain, NDC 63181-0013-1, UPC 8 429979 415707
- Manufacturer
- Sesderma, SL
- Category
- Drug — Sunscreen
- Hazard
- Affected units
- 15
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot code 41464901
- exp 05/17
Distribution
Part of a larger recall action
This product is one of 10 recalled by Sesderma, SL under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Sesderma, SL
See all →- ModerateSesderma Recalls Dryses Antiperspirant Solution for cGMP Deviations
FDA (Drugs) · 2016-05-18
- ModerateSesderma Salises Acne Gel Recalled for cGMP Deviations
FDA (Drugs) · 2016-05-18
- ModerateSesderma Sunscreen Recalled for cGMP Non-Compliance
FDA (Drugs) · 2016-05-18
- ModerateSesderma Recalls Repaskin 30 Sunscreen for cGMP Deviations
FDA (Drugs) · 2016-05-18
- ModerateSesderma Recalls Repaskin 30 Sunscreen for cGMP Deviations
FDA (Drugs) · 2016-05-18
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14